What Institut Pasteur d'Algérie does

Institut Pasteur d'Algérie (IPA) is a public scientific institution under the Algerian Ministry of Health, founded in 1894 and headquartered in Dely Ibrahim, Algiers. It is a member of the international Pasteur Network (PINA) and operates as Algeria's primary biomedical research and public health institute with approximately 180 employees. Its mandate spans medical diagnostic analyses, national reference laboratory functions, vaccine and biological product production, scientific research, and professional training. The institute delivers its services through four Algiers-area facilities (Dely Ibrahim, Sidi Fredj, El Hamma, and Kouba), supported by a web-based results portal and a dedicated anti-rabies vaccination center.

Service offerings include clinical and veterinary medical analyses, food and water safety testing, vaccination (yellow fever, rabies, seasonal influenza), anti-rabies post-exposure prophylaxis, importation and distribution of biological products, and NGS/bioinformatics training. IPA houses national reference laboratories for tuberculosis and antibiotic resistance surveillance; in 2024, surveillance recorded 18,512 new tuberculosis cases in Algeria (39/100,000 incidence), with an annual average of 49 MDR and 4 XDR TB diagnoses and a greater than 90% cure rate for properly treated cases. The institute's Quality Policy was renewed in 2024 and a Quality Manual issued in 2025.

Revenue mechanics are a hybrid of government appropriations (as a public institution), fee-for-service diagnostics and vaccinations, training course fees (20,000 DA per bioinformatics course for external candidates), and procurement tenders for biological products. Distribution is direct at physical facilities, with an online portal for laboratory results. Customer mix is dominated by the Ministry of Health and public healthcare institutions, with secondary demand from travelers, rabies-exposed individuals, and external researchers. The June 2026 designation by Africa CDC as the Regional Center of Excellence for Biosafety and Biosecurity for North Africa formalizes IPA's regional training and biosafety mandate beyond Algeria's borders.

Name

Institut Pasteur d'Algérie

Legal name

Institut Pasteur d'Algérie

Website

https://pasteur.dz

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

Institut Pasteur d'Algérie is Algeria's national public health institute under the Ministry of Health, delivering medical diagnostics, vaccine production, biological product importation, disease surveillance, vaccination services, and bioinformatics training across Algiers-area facilities, and now serving as Africa CDC's North African biosafety center of excellence.

Ownership category

akta.pro rank

Product category

Public Health Laboratory Services

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Medical Laboratories (621511), Administration of Public Health Programs (92312)

SIC

Biological Products, (No Disgnostic Substances) (2836), Services-Medical Laboratories (8071)

akta.pro primary industry

Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO) (HLAMAKAI)

akta.pro secondary industries

Vaccines & Public Health Product Distribution (CRAOAHAI), Vaccine Programs & Tendering (Government/NGO, Eradication Campaigns) (HLAMAKAO), Veterinary Public Health Laboratories (Reference & Confirmatory) (HLAMAJAH), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

Keywords

• Public health diagnostics
• Vaccine production
• Medical laboratory services
• Epidemiological surveillance
• Biological products distribution

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Pricing tiers

Distribution channels6 records

Marketing channels7 records

Core offering

Institut Pasteur d'Algérie is a public biomedical research and public health institute that provides medical, veterinary, and food/water laboratory diagnostics; produces and distributes vaccines and biological products; operates national reference laboratories for tuberculosis and antibiotic resistance; delivers travel and anti-rabies vaccination services; and conducts microbiology, virology, parasitology, and biosafety/biosecurity research and training.

Product overview

Institut Pasteur d'Algérie is a public health institution providing a comprehensive portfolio of laboratory diagnostic services, vaccine production, and scientific research. The organization operates as a multi-site facility with main sites in Dely Ibrahim (Alger), Annexe Sidi Fredj, Annexe El Hamma, and Annexe Kouba. Its core offerings include medical, veterinary, and food/water analyses; national vaccination services (yellow fever, rabies, seasonal influenza); production and distribution of biological products including vaccines; and research activities. The institution also serves as a training hub and hosts national reference laboratories for tuberculosis and antibiotic resistance surveillance.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Analyses (Analyses Médicales)
• Veterinary Analyses (Analyses Vétérinaires)
• Food and Water Analyses (Analyses des Aliments et des Eaux)
• Travel Vaccination and Counseling (Vaccination et Conseils aux Voyageurs)
• Anti-Rabies Vaccination Center (Centre de Vaccination Antirabique)
• Biological Products Production (Production de Produits Biologiques)
• Biological Products Importation and Distribution
• National Reference Centers (Centres Nationaux de Référence)
• Bioinformatics and NGS Training
• Scientific Research and Publications

Quantifiable outcome

• 18,512 new tuberculosis cases diagnosed in Algeria in 2024
• +4 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Institut Pasteur de Tunis: Sister Pasteur Institute in Tunisia operating under the same PINA network with a near-identical mandate combining medical diagnostics, vaccine production, research, and training. Most direct geographic and functional peer for IPA in the Maghreb.
• Institut Pasteur: The flagship Institut Pasteur in Paris and the founding member of the Pasteur Network. Directly comparable to IPA given the shared historical origin, network affiliation, and analogous mandate spanning diagnostics, research, vaccine production, and training.
• Institut Pasteur de Côte d'Ivoire: Pasteur Network institute in Abidjan delivering medical diagnostics, vaccination, and research with comparable reference lab functions. Useful benchmark for IPA's emerging regional ambitions in West/Central Africa.
• Institut Pasteur de Dakar: Senegal-based Pasteur Institute and a major vaccine manufacturer (e.g., yellow fever) for Africa. Comparable to IPA given its combination of diagnostics, regional reference lab functions, vaccine production, and network affiliation.
• Centre Pasteur du Cameroun: Cameroon-based Pasteur Network member delivering diagnostics, vaccination, and research under a similar public health reference structure. Useful peer for benchmarking IPA's diagnostic and reference lab service delivery in a comparable African setting.
• Institut Pasteur du Maroc: Moroccan Pasteur Network member delivering medical analyses, vaccination, research, and training. Operates in an immediately adjacent North African market with comparable public health role and service portfolio.

Broad incumbents

• bioMérieux: Global leader in microbiology diagnostics and infectious disease testing. Comparable to IPA in the microbiology testing domain, though operating as a commercial manufacturer of the reagents and platforms IPA uses in its reference labs.
• Africa CDC: Continental public health agency that designated IPA as a Regional Center of Excellence. Comparable as a coordinating reference and surveillance body across Africa, and the primary upstream counterparty for IPA's expanded regional mandate.
• National Institute for Communicable Diseases (South Africa): South Africa's national reference laboratory for communicable diseases. Comparable to IPA's National Reference Laboratory for Tuberculosis in scope, mandate, and role as a public-sector surveillance anchor.

Regional players

• Institut National de Santé Publique (INSP Algeria): Algeria's national public health agency and a direct in-country peer. Operates overlapping functions in epidemiological surveillance and public health program oversight, and is explicitly linked from IPA's website as a partner.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Pasteur_Algerie
• YouTubeyoutube.com/channel/UC4PRrpWCNic0AQfhBAD4bHg
• Facebookfacebook.com/Institut-Pasteur-dAlg%C3%A9rie-Officiel-160281417958383/?modal=admin_todo_tour
• LinkedInlinkedin.com/company/institut-pasteur-d-algerie
• Instagraminstagram.com/ipapasteur

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institut Pasteur d'Algérie